The vaccine has been developed from Suvaxyn Circo+MH RTU, and also contains MetaStim as adjuvant 1.
MetaStim is an emulsion containing a metabolisable (non-mineral) oil and is used in vaccines to help elicit both humoral and a cell-mediated immune responses. Zoetis says it is thought to preserve the vaccine components so the antigens are released slowly as compared to other types of adjuvants2.
Alvaro Aldaz, Director Commercial Development and Innovation, Swine, Zoetis, said: "The safety and efficacy of MetaStim has been well documented given its use in several swine, cattle and equine vaccines for the past several years.
"In fact, the MetaStim adjuvant is currently used in our bivalent vaccine – Suvaxyn Circo+MH RTU. Suvaxyn Circo is the monovalent PCV2 fraction of the parent vaccine and it delivers a similar performance profile for PCV2 protection."
More than 250 million pigs are vaccinated against Circovirus every year in Europe.
Professor Hans Nauwynck, Director of the Laboratory of Virology at Ghent University said: "Vaccination of piglets against Circovirus has become a standard in pig farms across Europe.
"The goal is achieving strong immunity, both cell mediated and antibodies, against a virus that is always in the farm.
"Veterinarians should consider several factors when deciding the best timing for vaccination, being especially important the levels of maternal immunity in the pigs to be vaccinated, the presence of co-infections like PRRSV and the expected infection pattern in the farm."
Suvaxyn Circo is a new tool for veterinarians and producers who prefer monovalent vaccines. In situations where early vaccination of piglets against M.hyo is preferred, for example using Suvaxyn MH-One which is licensed for administration from one week of age, there will be a need to give a separate monovalent vaccine to cover PCV2. In such cases, Suvaxyn Circo from three weeks of age can be considered as an option.
Suvaxyn Circo is available in 50- and 125-dose vials.
For more information, contact your Zoetis representative.
References
Stefano qualified in Parma, Italy and has a Master’s in Clinical Oncology. He has worked in a number of referral practices, managing and treating small animal oncological cases. He also has an interesting history of working with animals across the globe: he has a Master’s in Tropical Veterinary Medicine and worked with the United Nations in Somalia, Malaysia and Guyana in wildlife management.
Founder, CEO and Clinical Director of The Ralph, Shailen Jasani said: "We had always planned to include an oncology service here at The Ralph though not quite this soon after opening. However, over the last eight months, this has been one area of veterinary medicine where we have not been able to serve our patients, their carers or our referral community. This did not sit well with us. Serendipity being what it is, our path crossed with Stefano's and we were able to extend our services."
For more information, visit www.theralph.vet
In previous years, candidates were only asked to provide manifestos, which often contained information that wasn't especially relevant to whether or not they should be elected to Council.
Now, they are asked to share their reasons for wanting to be elected, what they can bring to Council and what experience they have.
That should make it much easier for voters to pick the right candidates, which is no bad thing because there are 20 vets standing this year, a record since electronic records began in 1997 and 1 more than the previous best in 2014.
This year’s candidates are:
Louise Allum MRCVSSam Bescoby MRCVSAndrew Clemence MRCVSTshidi Gardiner MRCVSReginald Godwin MRCVSPaddy Gordon MRCVS Danielle Greenberg MRCVSGerard Henry MRCVSRichard Hillman MRCVSBenjamin Kennedy MRCVSDarren Partridge MRCVSMartin Peaty MRCVSAlison Price MRCVSPeter Robinson MRCVSJennifer Simmons MRCVSSadie Spencer MRCVS Mary Thomas MRCVSWilliam Wilkinson MRCVSLara Wilson MRCVS
and the inevitable Tom Lonsdale MRCVS.
The full biographies and election statements for each candidate are available to read at www.rcvs.org.uk/vetvote25.
The four candidates who get the most votes will take up their four-year terms on RCVS Council at the College’s Annual General Meeting on Friday 4 July 2025.
Simon Wiklund, Assistant Registrar and Returning Officer for both elections, said: “We are glad to see such a large number of veterinary professionals putting themselves forward as candidates for this year’s elections.
"It is worth noting that any future governance changes, including RCVS and VN Councils becoming all-appointed bodies, are contingent on new legislation and, until that happens, we will continue to hold our annual elections.
“You may have also noticed some differences with this year’s elections, particularly in terms of the candidate statements.
"This is thanks to a change to our election scheme, which provides greater flexibility about how we run our elections, and the information that we can ask the candidates to submit.
“This means that, rather than asking candidates for a broad manifesto statement, we’ve asked them to answer key questions that are relevant to the role of a Council member, including what skills and experiences they can bring to the table.”
Ahead of the elections, RCVS will be running its ‘Quiz the candidates’ initiative in which veterinary surgeons can submit questions to the candidates standing in their respective elections, in order to better understand them and their views.
However, due to the additional information now included in each of their statements, this year candidates will only answer one question of their choice each.
Before submitting questions to the candidates, please note the RCVS will only accept one question per person. Offensive, defamatory and inaccurate questions will be rejected by the Returning Officer and not be passed on to candidates.
Veterinary surgeons can submit a question to the RCVS Council candidates by emailing vetvote25@rcvs.org.uk.
Novartis Animal Health UK has announced a strategic partnership with Procter & Gamble (P&G) Pet Care, maker of the Eukanuba and Iams brands.
As part of the arrangement, the Novartis sales team will start detailing P&G's pet nutrition products to veterinary practices from April 1, 2014 in the UK and at a later stage in Ireland.
Novartis says the partnership brings together two highly complementary portfolios: Novartis is a leader in pet health areas in which P&G's Eukanuba Veterinary Diets have acknowledged strong clinical formulations, specifically dermatology, nephrology, and orthopaedic conditions. The partnership is designed to offer veterinary surgeons a holistic and flexible portfolio in key canine and feline health areas, as well as increased commercial and technical support and partnership from the Novartis sales team.
Simon Harris, sales & marketing manager at Novartis said: "Novartis Animal Health already offers expertise in key companion animal diseases together with innovative veterinary medicines. Based on research done with veterinary customers, we believe nutrition also plays an important role in disease management in pets, making our strategic cooperation with P&G Pet Care a natural fit that offers real benefits to veterinarians and their patients."
Dr. Penny Watson, Senior Lecturer in Small Animal Medicine at the University of Cambridge, said: "Clinical nutrition plays a key role in patient management and is an important complement to medicine in order to achieve a successful outcome. This combination of Eukanuba Veterinary Diets and Novartis Animal Health products helps highlight the importance of dispensing clinical diets as part of a multi-modal approach to effective patient management. Additionally, high quality nutrition is also recommended by vets as part of a normal day-to-day healthy lifestyle."
The partnership will be launched at the BSAVA Congress. The two companies say they'll have a joint presence at the event to showcase the strength and versatility of the combined Novartis and P&G Pet Care portfolio to the veterinary community.
The company says that the 20 module medicine programme, covering all of the major body systems of cats and dog, combines the latest thinking in small animal medicine with its world-class learning resources to ensure that delegates’ learning experience online gives the same high-quality learning as the attendance programme.
Improve says it aims to offer a route for veterinary surgeons who don’t have the time to participate in an attendance programme or who work in countries where this type of training is not available, the opportunity to study for a recognised postgraduate qualification.
Delegates signing up for the programme will have a module tutor – an RCVS or ECVIM/ACVIM Small Animal Internal Medicine Diploma holder – and a dedicated programme tutor who works with individual delegates to ensure they are supported throughout the programme.
Improve says the course includes interactive and engaging modules, together with real-life case studies, presentations, written notes, interactive quizzes and exercises.
Dr Alison Babington MRCVS, Business Coordinator at Improve said: "The pressures on veterinary professionals today have never been more intense and many of us struggle to find the work-life balance which is so important for our well-being. Unfortunately, these pressures often preclude many vets from undertaking the type of postgraduate training which could give them additional job satisfaction and enhance both their career prospects and the profitability of their practice.
"It has been our ambition for some time to offer some of our flagship programmes online and, in creating the Distance Learning Small Animal Medicine programme, we drew on the experience of the latest online platforms.
"This new Distance Learning Programme offers a high quality interactive, engaging Small Animal Medicine learning experience which will be fun to study and a far cry from the days of simply reading text online. It will be accessible to vets working anywhere in the world and we’re very proud to be able to offer a high level programme via this learning route."
For more information visit: www.improveinternational.com or ring 01793 759159.
AceSedate for horses contains 10mg/ml acepromazine as its active ingredient, which the company says means a lower dose volume is required compared to the non-UK licensed equine acepromazine options available.
The dosage of AceSedate is 0.03-0.10 mg per kg bodyweight, however Jurox recommends that the lower end of the dose range is always selected where possible. It can be administered via intramuscular or slow intravenous injection.
AceSedate is supplied in a multidose vial and the shelf life after opening the immediate packaging is 28 days.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "The launch of AceSedate means injectable acepromazine is now licensed in the UK for horses, giving vets peace-of-mind that a licensed product is now available. It is a welcome addition to our equine anaesthesia, analgesia and sedation portfolio."
For more information, visit: www.jurox.com/uk, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail customerservice@jurox.co.uk.
The materials include eye-catching waiting room bunting, wall displays, posters, leaflets and leaflet holders which offer hints and tips on how to look after pets while fireworks are going off.
Ceva is also launching a series of eight three-minute fireworks videos which offer advice to owners about how they can 'Help take the fear out of fireworks' and more information about Adaptil and Feliway. The videos are presented by Emma Carr, training and charity key account manager at Ceva Animal Health and are available to download via Vimeo and Ceva’s social media tool kit.
Veterinary practices are being encouraged to use the new materials to take part in Ceva’s annual fireworks waiting room display competition, which offers a £200 voucher for the overall best display and luxury chocolate hampers for 10 runners up (hint: entrants get additional credit if they build a display den and plug in an Adaptil Calm Home Diffuser nearby).
Practices taking part in the competition can post pictures of their dens and waiting room displays on Ceva Animal Health UK's Facebook page in October.
Abigail King, senior behaviour product manager at Ceva Animal Health, said: "The extensive marketing support we are putting behind Adaptil and Feliway in the run up to the fireworks season will help educate pet owners on the measures that can be put in place to help their pets with firework fears, while highlighting the benefits of our products."
For further information, or to request the new waiting room material, contact your local account manager or email: cevauk@ceva.com.
Tolracol is a 50mg/ml suspension of toltrazuril which can be used in all three species to prevent coccidiosis infections in youngstock on farms with a history of the disease.
Krka’s head of sales and marketing, Killian Gaffney said: "Coccidiosis can have a devastating impact on young animals, resulting in ill-thrift, weight loss and potentially death, making its prevention a vital component of herd or flock management.
"Importantly, this is a tri-licence single dose product which requires vet prescription. The involvement of the vet in prescribing coccidiostats is important as their use should be part of a whole management approach to prevention."
Krka says Tolracol should be used ahead of the peak infection period on farms with a pre-existing coccidiosis problem, with it recommended for use in neonatal pigs at three to five days old and as soon as required in calves and lambs.
Mr Gaffney added: "This product has been proven in trials and offers a cost-effective option for farmers, it is also easily administered which farmers will find attractive. Krka is launching a new farmer campaign to support Tolracol.
"With lambing and spring calving now taking place across the country vets are likely to be asked in the coming weeks and months about coccidiosis prevention. Tolracol provides another valuable tool in the armoury when it comes to preventing this nasty condition and should be considered as a first-choice product."
For more information, see the SPC or contact Krka UK Limited on +44 (0) 2071 646 156.
Eravac is an injectable emulsion ready for administration without the need for reconstitution beforehand. Containing 10 vials with individual doses, the new presentation is is indicated for the immunisation of pet rabbits from 30 days of age.
For more information, visit: https://www.hipra.com/portal/en/hipra/animalhealth/products/detail/eravac-pets
Jane (or John) Doe was charged with having stolen midazolam, butorphanol and promethazine hydrochloride from their practice for use other than for veterinary purposes, making false clinical records concerning the use of drugs on their own dogs to disguise the fact that the drugs were instead being used for non-veterinary uses, and drawing up medication taken from the practice into a syringe for the purpose of self-medicating.
In addition, they were charged that their conduct was dishonest.
The Committee found it proven that Jane/John Doe had taken approximately 150 vials of midazolam, 87 ampoules, 112 tablets and one elixir bottle of promethazine hydrocholoride, and 0.2mls of butorphanol together with Iml of midazolam for their dog at a time when their dog was, in fact, dead.
The Committee also found it proven that the defendant had drawn up medication for the purpose of self-medicating, and had created false clinical records.
In deciding the sanction, the Committee concluded that the respondent had abused their position of trust, that their actions were dishonest, prolonged and repeated in nature, and undermined the reputation of the profession as a whole.
Therefore the only appropriate action was removal from the Register.
Unusually, the RCVS did not issue a press release about this case, as it normally does.
There was also a protracted delay between the hearing and the report of the hearing being published on the College website.
Furthermore, when it was finally published, the report had been redacted to remove any reference to the name, gender or location of the respondent.
When asked why, the College said: "Matters of a highly confidential nature arose following the hearing which led to a delay in the decisions being published.
“The decisions have been redacted and we cannot provide the reasons for the redactions as that would necessarily involve disclosure of confidential and personal information.
"However, the circumstances are considered to be exceptional and the College’s decision to make the redactions was only made following very careful consideration of evidence provided to the RCVS.
"The decision has been published on the RCVS website in its redacted form and in view of the timeframe and the circumstances, it has not been considered appropriate to issue a press release.”
CommentThe College will for sure have had very good reasons for redacting the name of the respondent in this case.
One has to assume there must have been a very real threat to the respondent’s life, and under those circumstances, confidentiality is absolutely right and proper.
However, whatever the reason, secrecy is never a good look, especially when it comes in the form of a cape worn by a regulator.
So it is frustrating to hear that the College has again made a rod for its own back, when it could so easily have included a very general one-line explanation for why it felt redaction was necessary, without compromising the individual’s confidentiality.
It would have been enough, for example, just to say that the College felt there was a risk to life. People would accept that.
The study "Influence of dietary restriction and low-intensity exercise on weight loss and insulin sensitivity in obese equids" was carried out by Nick Bamford and colleagues at the University of Melbourne’s Faculty of Veterinary and Agricultural Science, in collaboration with Spillers.
A total of 24 obese horses and ponies were randomly divided into two groups; 'restricted diet only' or 'restricted diet plus exercise'. All horses and ponies were fed the same diet of restricted hay (no grazing), a small amount of alfalfa chaff and soya bean meal, and a vitamin and mineral supplement.
The exercise programme, which was designed following feedback from horse owners to help ensure it could be implemented relatively easily in the real world, consisted of 15 minutes of brisk trotting (with a five minute walk before and after) five days per week for 12 weeks.
The 'restricted diet only' group showed an overall reduction in body weight and body condition score. They had increased levels of adiponectin – a hormone produced by fat cells, low levels of which are a risk factor for laminitis. They had decreased baseline insulin, high levels of which have been linked to an increased risk of laminitis, and decreased leptin, high levels of which are associated with obesity.
Although exercise did not increase weight loss, it did produce additional benefits that were not seen in the 'restricted diet only' group, the most important one being improved insulin sensitivity. More insulin sensitive horses and ponies need to produce less insulin in order to control their blood sugar. This is important because high levels of insulin in the blood and/or reduced insulin sensitivity are risk factors for laminitis. Horses and ponies in the exercise group also had decreased levels of ‘serum amyloid A’, a protein that is a marker for inflammation.
Clare Barfoot RNutr, the research and development manager at Spillers said: "Reducing calorie intake and feeding a diet low in starch and sugar should be the priority for overweight horses and ponies. However, the results of this study suggest that exercise may offer additional health benefits for obese horses and ponies and/or those with ‘EMS’ that cannot be achieved by cutting calories and weight loss alone."
Reference
Photo: Spillers/Steve Bardens
The Davies Therapy and Fitness Centre has been developed following two years of planning with the intention of supporting referring practices.
Run by a team of Chartered Veterinary Physiotherapists, hydrotherapists and anaesthetists, it has a large hydrotherapy suite, a therapeutic exercise area and gym, an outdoor exercise area, four spacious consultation and treatment rooms and a bright and airy reception.
Services include physiotherapy, rehabilitation, underwater treadmill therapy, soft supports, splinting and orthotics, fitness and conditioning and acupuncture and pain management clinics.
Good rehabilitation is pivotal to the recovery process following injury or surgery and for the management of long-term conditions such as arthritis. DVS says owners are more likely to be compliant with veterinary rehabilitation and fitness programmes if they can fully understand the importance of the process by working with a friendly, professional team, preferably at a bespoke centre.
Diane Messum, Head of Physiotherapy said: "Our mission is to work with referring practitioners to treat every pet, and their owner, with the utmost care and compassion throughout the entire veterinary process. We aim to minimise pain and restore the animals we treat to their maximum physical and mental wellbeing, with the provision of expert therapy, fitness and pain management."
To find out more visit www.vetspecialiststherapy.co.uk
The online seminar, which equates to one hour’s CPD, features six UK experts in equine endocrinology, with the objective of supporting equine and mixed practice vets in using the clinical history to guide their interpretation of the basal ACTH test results and subsequent treatment decisions.
The speakers participating in the Equine Endocrine Pioneers Circle are:
Harry Carslake MA VetMB DipACVIM MRCVS: Senior lecturer in equine medicine at the University of Liverpool
Edd Knowles MA VetMB MVetMed DipECEIM MRCVS: Specialist in Equine internal medicine at Bell Equine Veterinary clinic
Professor Cathy McGowan BVSc DipVetClinStud MACVSc PhD DEIM DipECEIM FHEA MRCVS: Head of Department of Equine Clinical Science and Director of Veterinary Postgraduate Education at the University of Liverpool
Dr Nicola Menzies-Gow MA VetMB PhD DipECEIM Cert EM(Int Med) MRCVS: Reader in equine medicine at the Royal Veterinary College
Victoria South MA VetMB CertAVP(EM) DipECEIM MRCVS: Senior assistant at Liphook Equine Hospital
Nicola Steele BVM&S CertAVP(EM) MRCVS: Fyrnwy Equine Clinic and Director of Veterinary CPD (Equine and Large Animal)
The webinar considers when vets should test for PPID and decision-making on the best test to use, how to interpret grey zone results and also how to interpret problematic follow up tests. The experts have different opinions on some of these areas, allowing vets in practice to see the different ways in which cases can be viewed and managed.
These principles are then reinforced by the use of three clinical case scenarios with the patients all having the same basal ACTH result but a different selection of clinical signs.
Liz Barrett, equine business head at Boehringer Ingelheim said: "Since the launch of our Talk About Laminitis initiative in 2012, more than 50,000 horses have benefited from complimentary basal ACTH tests to aid the diagnosis of PPID, however two common areas of uncertainty in interpreting ACTH results still exist. Firstly, the interpretation of borderline, equivocal or ‘grey-zone’ results and when PPID treatment should or shouldn’t be recommended and secondly, the interpretation of follow-up ACTH test results and when to advise altering the treatment dose.
"The Equine Endocrine Pioneers Circle webinar allows vets to update their knowledge on this broad subject area and illustrates that there is often more than one way to approach the diagnosis, treatment and management of the PPID case."
To view the Equine Endocrine Pioneers Circle webinar on the Boehringer Academy visit https://www.boehringer-academy.co.uk/webinar/bil205
Dilaterol is an oral syrup containing 25 mgs/ml clenbuterol hydrochloride, indicated to treat respiratory disease in horses. It causes intense bronchodilation, inhibits histamine release and increases ciliary mucous clearance. It can be used as a frontline or adjuvant therapy.
Dilaterol is administered via food and comes in a 355 ml bottle with a pump dispenser for easy and accurate dosing.
Emma Jennings, Equine Brand Manager at Dechra said: “We are very pleased to have added Dilaterol to our comprehensive range of equine therapies as it is an established and effective treatment for bronchial conditions.
"It is particularly useful in cases of respiratory allergy, bronchospasm and equine asthma and is already regarded as a valuable tool for veterinary professionals."
Dilaterol will be available to order through wholesalers. For more information, visit www.dechra.co.uk.
VetFinders will recruit for permanent and locum positions for veterinary practices throughout the UK, from administration roles through to nursing staff and vets.
The agency has been founded by a man called Chris Worthington who previously built an engineering recruitment firm called Qualtech Resourcing.
Alongside Chris in the VetFinders team are recruiters Gabrielle Dawson and Martin Wilson, both with over 15 years’ experience in recruitment, Chris’s wife Anna, who is charge of accounting and payroll, and administrator Suzy Buttress.
Chris said: "VetFinders is a business with a purpose, a business with a force for good and a business with a double bottom line! Our approach is totally unique in the industry and it’s what sets us apart. Candidates are already hearing about our message and registering with VetFinders rather than other agencies.
"We have chosen four specific charities and our support for them does not stop at the point of donation. We will also be working closely with them, funding specific projects and working on their front line."
The chosen charities are:
Hope Pastures, in Leeds, which rescues, rehabilitates and re-homes horses, ponies and donkeys.
Moorview Rescue in Harrogate, which has re-homed almost 2000 dogs in the UK since it was set up as a registered charity in 2009.
Nuzzlets, a small charity based near Great Ouseburn in York which specialises in giving loving homes to unwanted animals and enabling young people free access to them for therapy and education.
Blue Cross.
When a candidate is placed by VetFinders, the client can choose which of the four charities they want a percentage of their fee to be donated to. The client and placed candidate will then be given regular updates of how their money has benefitted children and animals, including through photos, videos, emails and website updates.
For more information, visit: https://www.vetfinders.co.uk/
Photo: Top (L-R): Martin Wilson - Veterinary Recruitment Consultant, Chris Worthington - Managing Director. Bottom (L-R): Gabrielle Dawson - Veterinary Recruitment Consultant, Anna Worthington - Finance and Payroll Manager and Suzy Buttress - Administrator.
The manufacturer has identified that there is a potential for decreased levels of the preservative Chlorobutanol hemihydrate in the following batch: J2101-03 Expiry 11/2018.
Oxytobel is distributed in the UK by Bimeda UK. Veterinary practices that have purchased this batch number should contact Bimeda to arrange collection.
Any queries in relation to return of the product or credit for the product returned should be addressed to Kay Cowton, Bimeda UK Sales on 01248 725400 or email: uksales@bimeda.com
For further information on the recall please contact Bela-pharm GmbH & Co.KG: +49 (0) 44 41 873 294.
RSPCA has launched a new website called 'Political Animal' to encourage voters to lobby their prospective parliamentary candidates about animal welfare issues ahead of the General Election.
The site offers an interesting timeline of the last 20 years of animal welfare law, leading up to the Animal Welfare Act 2006, showing landmark changes. It also gives details of the RSPCA's stance on issues like status dogs, higher welfare farming, wild animals in circuses and animals used in experiments.
RSPCA parliamentary officer Stacey Frier, said: "The Political Animal microsite is a unique project allowing our supporters to drive the debate by letting politicians know what they want them to do for animal welfare if they are elected.
"The RSPCA and its supporters have been instrumental in campaigning for change in animal welfare legislation since the Society's creation in 1824 and we're urging the incoming parliament to continue to work with us to achieve further animal welfare milestones."
For more information, please log on to http://www.politicalanimal.org.uk/
Ceva Animal Health has announced that Vetergesic (buprenorphine), its long-lasting analgesic, is now back in stock and on special offer with the rest of the company's analgesic product range.
The company says it has appointed a new, dedicated Vetergesic manufacturing site and increased stock-holding facilities in order to guarantee a continuous long-term supply of the product, which is available in a 10ml vial for use in dogs, cats and horses and a 1ml single dose preparation for cats and dogs.
At the same time, Ceva has launched a spring offer on its entire analgesic product range, which runs till the end of April. For every two packs of Vetergesic, Carprodyl F or Dolagis purchased, veterinary practices will receive one pack free and for every four packs of Meloxidyl purchased, practices will receive one pack free. In addition, practices will be able to take advantage of ongoing rebates through the new CevaSave Rebate Programme.
For further information, contact your local Ceva territory manager, email analgesics-group@ceva.com or call 01494 781510.
The company says it has already used part of the funding facility to acquire six practices – four in Wales and two in South London, with the aim to attain many more practices in 2017 across the UK.
Medivet now has 169 veterinary practices across the country, making it the fourth largest veterinary group in the UK.
Will Taylor, Corporate Relationship Manager for HSBC in Thames Valley, said: "It is great to see that Medivet has gone from strength-to-strength over the past few years, with an ambitious business. HSBC has enjoyed a long-standing and highly effective business relationship with Medivet and this latest deal will allow the business to carry out its aspiring acquisition plan and continue to grow at a rapid pace."
Dr Arnold Levy, Chief Executive Officer at Medivet, said: "This latest round of funding will allow us to take up a vast amount of opportunities that have become available to us and accelerate the pace of acquisitions of further practices across the country. Last year we acquired over 50 new sites and this year we plan to attain even more, which is significant progress for our business and testament to our strong financial backing."
CCTV will be required in all areas where live animals are present, with unrestricted access to footage for Official Veterinarians.
In addition, the Government has also announced that it will be modernising statutory animal welfare codes to reflect enhancements in medicines, technology and the latest research and advice from veterinary surgeons. The codes will remain enshrined in law and the first to be updated will cover chickens bred for meat.
Consultations on these proposals have been launched this morning (https://consult.defra.gov.uk/farm-animal-welfare/cctv-in-slaughterhouses/ and https://consult.defra.gov.uk/animal-health-and-welfare/code-of-practice-for-the-welfare-of-meat-chickens/)
Environment Secretary Michael Gove said: "We have some of the highest animal welfare standards in the world and the actions I am setting out today will reinforce our status as a global leader.
"As we prepare to leave the EU, these measures provide a further demonstration to consumers around the world that our food is produced to the very highest standards."
BVA President Gudrun Ravetz said: "Today’s announcement is extremely welcome. We have been campaigning on this issue for a number of years and this announcement represents a huge win for animal health and welfare in England.
"Mandatory CCTV in all areas of slaughterhouses will provide an essential tool in fostering a culture of compassion that could help safeguard animal welfare and we are particularly pleased to see a commitment to Official Veterinarians having unrestricted access to footage.
"Vets' independence and unique qualifications help ensure that the UK will continue to have the highest standards of animal health, welfare and food safety.
"We recognise that the cost of installing CCTV may be a burden for some very small abattoirs, but it is important that the animals we farm for food have both a good life and a humane death and CCTV has a key role to play in ensuring these requirements are met."
Gudrun added: "We welcome the consultation to update welfare codes for farmed animals and pets, many of which are in urgent need of updating to reflect the latest animal welfare science and good practice. We are keen to see Defra working with the veterinary profession, industry and all relevant stakeholders to ensure vital welfare codes are brought up to date."
John Tasker of the British Veterinary Poultry Association said: "BVPA are committed to supporting research and implementation of best practice in all aspects of poultry production, including welfare on farm and in the abattoir. We look forward to cooperating fully with Defra in development and implementation of these new initiatives. The British poultry industry has some of the highest welfare standards in the world and seeks to continually update and refine its practices in the light of new research, and to maintain public confidence in the industry."
Photo: Lititz, Pennsylvania. Hoisting a slaughtered steer in Benjamin Lutz's slaughterhouse, 1942. Wikipedia.
Zoetis has announced the launch of Zulvac SBV, a new Schmallenberg vaccine licensed for use in cattle and sheep in two doses at a three week interval, the second at least two weeks before mating.
Zulvac SBV is licensed for use in cattle and sheep in two doses at a three week interval, the second at least two weeks before mating.
Duration of immunity is six months in cattle and seven in sheep. At the recommended vaccination timing, this covers the window of susceptibility during pregnancy; in sheep from day 28 to 56, and days 70 to 150 in cattle. Animals infected during these periods are at risk of malformed offspring and subsequent stillbirth.
The company says vaccination combined with insecticidal measures to control the midge vector remains the most effective way of protecting the population1 and ensuring a more unified level of immunity.
Zoetis vet Carolyn Hogan said: "Although SBV is now considered to be an enzootic pathogen in England and Wales, there is plenty of evidence that seroprevalence at farm level – particularly on sheep farms - varies. As immunity wanes, the proportion of herds and flocks naïve to SBV and at risk via introduction of naïve replacements increases. So the risk of reinfection in assumed enzootic areas is potentially underestimated2.
"Culicoides midges, the SBV vector, are widespread in Europe and move easily between farms and regions, allowing rapid spread of infection."
Carolyn says that whilst there have been no confirmed diagnoses of congenital abnormalities in calves or lambs from APHA in 2014 or 2015, unconfirmed anecdotal cases have been reported.
"We do not know whether our ruminant population is immune or susceptible and neither do we know if another SBV challenge will appear. Vaccination remains the most effective way of ensuring valuable livestock are protected."
Supplies are available immediately.
Tim was the principal veterinary surgeon at Nine Mile Veterinary Group in Wokingham, Berkshire, from its opening in 1985. He grew the business from one vet and three staff to 16 vets and 60 staff, before selling to CVS in 2007.
Thereupon he became the National Veterinary Director for CVS, supporting the business as it grew from 200 to 1200 vets and supporting individual vets and practices with management advice and clinical practice.
In more recent times Tim has been working with a peripatetic surgery group.
Tim has worked at Guide Dogs before: between 1987 and 2007, he was a Centre Veterinary Advisor at the charity’s now-closed site in Wokingham.
Tim said: “Guide dogs are fantastic to work with – they are good-natured and easy to handle, and the owners always have the best interests of the dog at heart. Plus, you know you are helping more than someone’s pet, a working dog making a real difference to a person’s life. A guide dog needs to be happy and healthy to fulfil its role. It all adds up to a very different flavour of vet work.
“I am looking forward to being back, but in a more central role with more strategic responsibility. The veterinary world has changed so much, even in the last ten years, and it will be good to draw on my experiences to help Guide Dogs traverse that change.
“It’s important that we keep the healthcare of guide dogs at the top of the priorities list; the dogs have always been at the very core of the charity. It’s crucial that we have solid relationships with veterinary practices, to ensure our dogs receive the greatest care at the best value to the charity."
The practice was formed earlier this year by Jade Statt and Sam Joseph, two veterinary surgeons who, quite separately, had been inspired by the bond between homeless people and their dogs and decided to do what they could to help. Each hit the streets, Jade in Westminster and Sam in North London, offering healthchecks and basic flea and worm treatment to the homeless. Unbeknownst to each other, they worked under the same name of Streetvet.
Their paths crossed earlier this year, whereupon they decided to join forces and create a proper framework through which to deliver not just preventative care for the majority of animals that are well cared for and healthy, but treatment for those that need it. So Streetvet was born.
Since then, the practice has grown to a 65-strong team of volunteer veterinary surgeons and nurses providing a free, first opinion veterinary service across London, supported by drug companies, veterinary practices, animal welfare charities, social non-profit organisations and local councils.
Jade said: "We have vets out in the community at least 4 days a week and everything that can be done in a consultation room, we can perform on the street. This includes medicating, vaccinating, blood sampling, urine analysis, lump sampling, microchipping and more.
"When we meet a dog that needs more advanced treatment we are able to take them to one of the practices that we work at to perform procedures including neutering, dental work, surgery, diagnostic imaging and even hydrotherapy.
"Being vets, we love animals, but much of our day-to-day work involves caring for their owners as well. Many of the owners that we meet are vulnerable people and one of the main benefits of having vets out on the streets is that we get to know the owners and their dogs and gain their trust.”
Streetvet will be launching in Brighton on Sunday 26th November and in Bristol on 2nd December.
if you are in the Brighton or Bristol area and want to volunteer, offer practice support or get involved with fundraising, email: info@streetvet.co.uk.
Veterinary professionals across the UK are also encouraged to email their interest in volunteering, to help StreetVet build its database and in time set up StreetVet UK-wide.
The two best research projects were selected on the awards day with Sara Hillyer from the University of Bristol School of Veterinary Sciences winning the £1,000 top prize for her project on vascular endothelial glycocalyx shedding in clinical disease in cats and dogs.
Nicola Mawson from the Royal (Dick) School of Veterinary Studies won the £500 runner-up prize for her project on feline tooth resorptive lesions.
The other four successful candidates were Emily Clark from the University of Nottingham School of Veterinary Medicine & Science, Luca Fortuna from the Royal Veterinary College London, Jessica Lam from the Royal (Dick) School of Veterinary Studies, and Xaquin Castro Dopico from the Royal (Dick) School of Veterinary Studies. Each were awarded £1000 towards their research.
Michelle Townley, Veterinary Advisor and Bursary Co-ordinator at MSD Animal Health said: "We were delighted that we had so many applications this year and again the standard of research and presentation was extremely high. The winning students presented on a very wide range of research areas and selecting just two winners proved extremely hard. It is very encouraging to see such enthusiasm for research in the vets of the future."
Applicants were judged on the quality and clarity of their research project, and their ability to clearly communicate their conclusions.
Applications for the MSD Animal Health Veterinary Student Research Bursary 2018 will be opened early next year. For further information, visit: www.msd-animal-health.co.uk/company-overview/student-research-bursary.aspx
CVS says the new hospital, which will be based at Central Park, Avonmouth, will be custom-built with uniquely designed facilities, state-of-the-art diagnostic tools such as MRI and CT scanners, and a cutting-edge stereotactic linear accelerator for radiotherapy in cancer treatment, the only one of its kind for pets in England.
The hospital, which will open next summer, will employ over 100 people led by a team of Specialist veterinary surgeons and supported by residents, interns and registered veterinary nurses.
Planning permission has been granted for the project, and CVS is now appointing building contractors.
Richard Fairman, CEO of CVS Group, said: "We are extremely excited to be developing this innovative new specialist veterinary hospital in Bristol, providing the best animal care to pet owners across the South West. With state-of-the-art equipment and some of the highest qualified veterinary professionals, we are confident that the site will act as a centre of excellence in the veterinary world, and be a leader in Europe for cancer treatments.
"The new hospital signals our commitment to investing in cutting-edge technology to bring cancer treatment in pets to the next level. It will provide a number of employment opportunities and secure specialist veterinary skills in the Bristol area. We look forward to finalising development plans and opening the doors to pet owners in 2022."